Qingxin Zhou#, Meihua Lin#, Xing Feng#, Fei Ma#, Yuekun Zhu, Xing Liu, Chao Qu, Hong Sui, Bei Sun, Anlong Zhu, Heng Zhang, He Huang, Zhi Gao, Yongxiang Zhao, Jiangyun Sun, Yuxian Bai, Junfei Jin*, Xuehui Hong*, Chang Zou*, Zhiyong Zhang*. Targeting CLK3 Inhibits the Progression of Cholangiocarcinoma by Reprogramming Nucleotide Metabolism. J Exp Med, 2020, 217(8):e20191779. (SCI, JCR1, Nature Index, IF: 10.892)